Efficacy rate alone not enough to determine overall value of a vaccine Many have highlighted AstraZeneca’s apparent 62% efficacy as a reason for Australia to seek out alternatives, but the candidate has a number of other significant advantages.
How important are COVID vaccine efficacy rates? Experts weigh in on whether greater investment in candidates with a higher efficacy rate would actually provide greater promise of elimination.
Vaccines that do not prevent or cure COVID still beneficial: Study As Australia moves closer to its COVID vaccine rollout, experts discuss new US modelling that suggests reducing the virus’ contagious period could prevent millions of cases.
What Australia’s vaccine roadmap means for GPs UPDATED: Will GPs be considered frontline healthcare workers? Will they have a role in aged care? RACGP President Dr Karen Price provides some insight.
Concerns raised over pharmacists’ role in COVID vaccine rollout Queensland Health has taken steps to include pharmacies in the vaccination program. But will it come at the cost of patient safety?
RACGP in talks with Federal Government over COVID vaccine rollout President Dr Karen Price gives newsGP a detailed update on logistics and funding, assuring GPs they will be a vital part of the process.
Vaccine not Australia’s COVID transmission ‘silver bullet’ A new report informed by leading experts urges a multi-pronged response to the pandemic in 2021. But what does that look like?
How will GPs tackle COVID vaccine hesitancy? Events like this week’s abandoned University of Queensland trial are unlikely to inspire confidence in people with questions about the safety of a COVID vaccine.
Peer-reviewed AstraZeneca data raises questions over vaccine rollout Publication of the highly anticipated data has highlighted the need for further trials to confirm dosage and efficacy.